46
Participants
Start Date
June 30, 2011
Primary Completion Date
April 30, 2012
Study Completion Date
June 30, 2012
Placebo
An infusion lasting approximately 60 minutes
PF-04950615 (RN316)
An infusion lasting approximately 60 minutes
PF-04950615 (RN316)
An infusion lasting approximately 60 minutes
Altoona Center for Clinical Research, Duncansville
National Clinical Research - Richmond, Inc., Richmond
Wake Internal Medicine Consultants, Inc., Raleigh
Wake Research Associates, LLC, Raleigh
DeGarmo Institute of Medical Research, Greer
Atlanta Diabetes Associates, Atlanta
Avail Clinical Research, LLC, DeLand
Compass Research, LLC, Orlando
Kendall South Medical Center, Inc., Miami
Innovative Research of West Florida, Inc., Clearwater
Achieve Clinical Research, LLC, Birmingham
Holston Medical Group, Kingsport
Advance Clinical Research, St Louis
Saint Luke's Hospital, Kansas City
Saint Luke's Lipid and Diabetes Research Center, Kansas City
Midwest Cardiology Associates, Overland Park
Stark Pharmacy, Overland Park
Vince and Associates Clinical Research, Overland Park
Lynn Health Science Institute, Oklahoma City
Oklahoma Cardiovascular Research Group, Oklahoma City
Oklahoma Heart Hospital Physicians, Oklahoma City
Oklahoma Heart Hospital, Oklahoma City
Texas Center for Drug Development, Inc, Houston
Martin Diagnostic Clinic, Tomball
Aspen Clinical Research, LLC, Orem
Collaborative Neuroscience Network, Inc., Long Beach
Elite Clinical Trials, Inc., Wildomar
Advance Outcome Management, Inc., Garden Grove
Collaborative Neuroscience Network, Inc, Garden Grove
The Medical Arts Health Research Group, Kelowna
Q & T Research Chicoutimi, Chicoutimi
Centre de Recherche Clinique de Laval, Laval
Diex Research Montreal Inc., Montreal
Clinique des Maladies Lipidiques de Quebec Inc., Québec
Diex Research Sherbrooke Inc., Sherbrooke
Lead Sponsor
Pfizer
INDUSTRY